Isolated noncompaction of the left ventricular myocardium in adults: a systematic overview

Nisha L Bhatia1, A Jamil Tajik, Susan Wilansky

  • 1Cardiovascular Division, Mayo Clinic Arizona, Scottsdale, Arizona 85259-5499, USA.

Insights

Adult left ventricular noncompaction (LVNC) outcomes are better understood through this systematic overview. This rare cardiomyopathy, diagnosed by echocardiography, shows significant risks of cardiovascular events and familial tendencies.

Area of Science:

  • Cardiology
  • Genetics
  • Echocardiography

Background:

  • Left ventricular noncompaction (LVNC) is a rare cardiomyopathy with poorly understood long-term outcomes due to inconsistent diagnostic criteria and small patient cohorts.
  • This condition can lead to serious cardiac events.
  • Understanding the natural history of adult LVNC is crucial for patient management.

Purpose of the Study:

  • To systematically review and delineate the long-term outcomes and natural history of adult left ventricular noncompaction (LVNC).
  • To consolidate data from eligible studies to provide a clearer picture of LVNC prognosis.

Main Methods:

  • A systematic overview was conducted using comprehensive computerized searches for "noncompaction" and related terms.
  • Reference lists of identified articles were hand-scanned to find additional eligible studies.
  • Data from 5 studies, comprising a combined cohort of 241 adult patients with isolated LVNC diagnosed via similar echocardiographic criteria, were analyzed.

Main Results:

  • The combined cohort (n=241) was followed for a mean of 39 months.
  • Annualized event rates included 4% for cardiovascular deaths, 6.2% for major adverse cardiovascular events (death, transplantation, ICD shocks), and 8.6% for all cardiovascular events (death, stroke, transplantation, ICD shocks).
  • Echocardiographic screening revealed familial occurrence of LVNC in 30% of index cases.

Conclusions:

  • Left ventricular noncompaction (LVNC) is an increasingly recognized cardiomyopathy diagnosed via echocardiography.
  • LVNC is associated with familial tendencies, arrhythmias, thromboembolism, advanced heart failure, and increased mortality.
  • The findings highlight the significant cardiovascular risks and hereditary nature of LVNC.
Abstract

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...